Axogen
Develops and markets surgical solutions for peripheral nerve repair
Company facts
- Founded
- 2002
- Employees
- 622
- Headquarters
- United States
- CEO
- Michael Dale
- Type
- Public
- Listed
- NASDAQ: AXGN
- Subsidiaries
- Axogen Corporation, Axogen Europe GmbH, Axogen Processing Corporation, Axogen Germany GmbH, Lectec
About
Axogen is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and healthcare providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen’s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile, and hug—some of the many things healthy peripheral nerves allow us to do. The company's commitment to the science of nerve repair sets it apart, as does its dedication to advancing patient care through innovative technologies. With a strong emphasis on research and development, Axogen continues to pioneer solutions that enhance the standard of care in peripheral nerve repair, ensuring that patients receive the best possible outcomes from nerve injury treatment.